IVF hartmann Holding AG's EBIT per Share for the
six
months ended in Dec. 2025 was CHF4.99.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was CHF8.93.
During the past 12 months, the average EBIT per Share Growth Rate of IVF hartmann Holding AG was -9.00% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 16.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 11.50% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 0.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for IVF hartmann Holding AG's EBIT per Share or its related term are showing as below:
XSWX:VBSN'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -35.5 Med: -3.5 Max: 49.1
Current: 16.2
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of IVF hartmann Holding AG was 49.10% per year. The lowest was -35.50% per year. And the median was -3.50% per year.
XSWX:VBSN's 3-Year EBIT Growth Rate is ranked better than 59.42% of 690
companies
in the Medical Devices & Instruments industry
Industry Median: 9.5
vs XSWX:VBSN: 16.20
IVF hartmann Holding AG (XSWX:VBSN) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
IVF hartmann Holding AG EBIT per Share Related Terms
IVF hartmann Holding AG EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF8.93
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVF hartmann Holding AG (XSWX:VBSN) has a EBIT per Share of CHF8.93 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on IVF hartmann Holding AG and its competitors. According to the industry distribution chart, IVF hartmann Holding AG ranks #280 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 40.6%.
Is IVF hartmann Holding AG's EBIT per Share too high?
IVF hartmann Holding AG's current EBIT per Share is CHF8.93. Based on the distribution chart, IVF hartmann Holding AG ranks #280 out of 690 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, IVF hartmann Holding AG has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IVF hartmann Holding AG's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, IVF hartmann Holding AG ranks #280 out of 690 companies for EBIT per Share. This puts IVF hartmann Holding AG in the upper half of its industry. The industry median EBIT per Share is 9.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.50, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on IVF hartmann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IVF hartmann Holding AG's current EBIT per Share is CHF8.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IVF hartmann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, IVF hartmann Holding AG (XSWX:VBSN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF143.21, compared to a current price of CHF129.00 — trading 9.9% below its estimated fair value. The current EBIT per Share is CHF8.93. IVF hartmann Holding AG's overall GF Score™ is 74/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For IVF hartmann Holding AG (XSWX:VBSN), the current EBIT per Share is CHF8.93 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IVF hartmann Holding AG (XSWX:VBSN) Overvalued in 2026?
Based on GuruFocus' analysis, IVF hartmann Holding AG stock appears to be undervalued.
The current stock price of CHF129.00 is trading 9.9% below its estimated GF Value™ of CHF143.21.
GuruFocus considers IVF hartmann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:VBSN:
EBIT per Share: CHF8.93
GF Value™: CHF143.21 vs. price of CHF129.00 (9.9% below fair value)
No single metric tells the full story. See the XSWX:VBSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
74GF Score
Get the complete analysis for XSWX:VBSN
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:VBSN has been successfully added to your 
